Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
PERI
ANTEROGEN
★
Anterogen 2025 Sales ↑, Operating Loss ↓, DFU Phase 3 Ongoing
05/15/2026, 03:48 PM
PERI
ANTEROGEN
★★
Anterogen: 1Q26 Sales Up 32%, Japan Approval for ALLO-ASC-EB
05/15/2026, 03:43 PM
PERI
ANTEROGEN
★★★
Anterogen: Japanese Approval for EB Therapy AlloStem and Revenue Growth
05/15/2026, 08:39 AM